A Study of AL2846 on Tolerance and Pharmacokinetics

NCT02779699 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: AL2846

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.